Christopher A. Kroeger

CIK: 0001658918

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)30 (85.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (8.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (5.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MPLT

MapLight Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (35 total)

MPLT
MapLight Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
73.7K shares at avg. $8.08$595K
MPLT
MapLight Therapeutics, Inc.
Aug 17, 2026
Award(A)
Direct
23.1K shares-
MPLT
MapLight Therapeutics, Inc.
Jul 17, 2026
Sale(S)
Direct
16.8K shares at avg. $37.90$636K
MPLT
MapLight Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
92 shares at avg. $37.96$3K
MPLT
MapLight Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
28.1K shares at avg. $37.26$1.0M
MPLT
MapLight Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
40.9K shares at avg. $36.46$1.5M
MPLT
MapLight Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
42.7K shares at avg. $36.99$1.6M
MPLT
MapLight Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
90 shares at avg. $37.54$3K
MPLT
MapLight Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
19K shares at avg. $36.00$682K
MPLT
MapLight Therapeutics, Inc.
May 18, 2026
Sale(S)
Direct
198 shares at avg. $28.15$6K
MPLT
MapLight Therapeutics, Inc.
May 18, 2026
Sale(S)
Direct
118K shares at avg. $27.19$3.2M
MPLT
MapLight Therapeutics, Inc.
May 11, 2026
Sale(S)
Direct
5.9K shares at avg. $30.56$180K
MPLT
MapLight Therapeutics, Inc.
May 11, 2026
Sale(S)
Direct
6.9K shares at avg. $30.04$206K
MPLT
MapLight Therapeutics, Inc.
May 11, 2026
Sale(S)
Direct
877 shares at avg. $28.70$25K
MPLT
MapLight Therapeutics, Inc.
May 11, 2026
Sale(S)
Direct
342 shares at avg. $27.57$9K
MPLT
MapLight Therapeutics, Inc.
May 8, 2026
Sale(S)
Direct
3.2K shares at avg. $29.20$94K
MPLT
MapLight Therapeutics, Inc.
May 8, 2026
Sale(S)
Direct
29.6K shares at avg. $27.48$814K
MPLT
MapLight Therapeutics, Inc.
May 8, 2026
Sale(S)
Direct
1.6K shares at avg. $28.56$45K
MPLT
MapLight Therapeutics, Inc.
May 7, 2026
Sale(S)
Direct
14.9K shares at avg. $28.47$424K
MPLT
MapLight Therapeutics, Inc.
May 7, 2026
Sale(S)
Direct
5.2K shares at avg. $29.15$152K
MPLT
MapLight Therapeutics, Inc.
May 6, 2026
Sale(S)
Direct
15.6K shares at avg. $29.13$455K
MPLT
MapLight Therapeutics, Inc.
May 6, 2026
Sale(S)
Direct
8.1K shares at avg. $28.04$227K
MPLT
MapLight Therapeutics, Inc.
May 5, 2026
Sale(S)
Direct
928 shares at avg. $29.00$27K
MPLT
MapLight Therapeutics, Inc.
May 5, 2026
Sale(S)
Direct
9.5K shares at avg. $28.12$268K
MPLT
MapLight Therapeutics, Inc.
May 4, 2026
Sale(S)
Direct
5.4K shares at avg. $28.37$154K

		Type	Shares	Price		Ownership
Oct 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	73,691	$8.08	$595,423	Direct
Aug 17, 2026	MPLT MapLight Therapeutics, Inc.	Award(A)	23,145	-	$0	Direct
Jul 17, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	16,779	$37.90	$635,924	Direct
Jul 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	92	$37.96	$3,492	Direct
Jul 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	28,091	$37.26	$1,046,671	Direct
Jul 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	40,899	$36.46	$1,491,178	Direct
Jul 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	42,738	$36.99	$1,580,879	Direct
Jul 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	90	$37.54	$3,379	Direct
Jul 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	18,950	$36.00	$682,200	Direct
May 18, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	198	$28.15	$5,574	Direct
May 18, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	118,037	$27.19	$3,209,426	Direct
May 11, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	5,890	$30.56	$179,998	Direct
May 11, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	6,871	$30.04	$206,405	Direct
May 11, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	877	$28.70	$25,170	Direct
May 11, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	342	$27.57	$9,429	Direct
May 8, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	3,205	$29.20	$93,586	Direct
May 8, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	29,624	$27.48	$814,068	Direct
May 8, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	1,582	$28.56	$45,182	Direct
May 7, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	14,880	$28.47	$423,634	Direct
May 7, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	5,220	$29.15	$152,163	Direct
May 6, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	15,603	$29.13	$454,515	Direct
May 6, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	8,098	$28.04	$227,068	Direct
May 5, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	928	$29.00	$26,912	Direct
May 5, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	9,544	$28.12	$268,377	Direct
May 4, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	5,427	$28.37	$153,964	Direct

1-25 of 35 transactions

About Kroeger Christopher A.

Kroeger Christopher A. (SEC CIK 0001658918) files insider reports with the SEC as Chief Executive Officer of MapLight Therapeutics, Inc. (MPLT).

Signal8 holds 11 ownership filings by Kroeger Christopher A. (1 Form 3, 10 Form 4), filed between Oct 27, 2025 and Oct 16, 2026. Those filings report 35 transactions, from Oct 27, 2025 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kroeger Christopher A.'s filings is in REDWOOD CITY, CA.

Recent filings by Kroeger Christopher A.

Oct 15, 2026: Open-market sale of MPLT shares (Form 4, code S).
Aug 17, 2026: Grant or award of MPLT shares (Form 4, code A).
Jul 17, 2026: Open-market sale of MPLT shares (Form 4, code S).
Jul 16, 2026: Open-market sales of MPLT shares (3 lines, Form 4, code S).
Jul 15, 2026: Open-market sales of MPLT shares (3 lines, Form 4, code S).

Other insiders filing for MapLight Therapeutics, Inc. (MPLT)

Kreitzer Anatol, Chief Discovery Officer
GILLIS JONATHAN, CAO and Interim CFO
Lillie James Woodruff, Chief Scientific Officer
Hanson Kristopher, General Counsel
Foff Erin Pennock, Chief Medical Officer
Cox Troy, Director

How to read Form 4 transaction codes